Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
76,526.10
(
-0.21%
)
News Focus
News Focus
Post# of 518750
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

attilathehunt

Send PM Follow Ignore
Followers 71
Posts 9094
Boards Moderated 0
Alias Born 03/06/2016

attilathehunt

Re: Amatuer17 post# 155490

Wednesday, 07/04/2018 3:17:27 AM

Wednesday, July 04, 2018 3:17:27 AM

Post# of 518750
So, what if only 10% of people with Alzheimer’s have genetics that predispose them to effective treatment with Anavex 2-73? If that were the case (I don’t see that it will be), the drug”

I believe the % is far greater than 10%. I cant imagine the trial will start in a month if the % was only 10%. My guess is the % is at least 25%.

Seeing the news about a trial starting is very welcome news. Finally!!

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News